THE report recently released by the United Nations High Level Panel on Access to Medicines (UNHLP) has drawn criticism from pharmaceutical corporations and industry groups.
Some of these groups are saying that the report calls for taking R&D out of the hands of entrepreneurs.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
